Davis Polk Advises Roche on Its Acquisition of Flatiron Health
Davis Polk is advising Roche on its $1.9 billion acquisition of Flatiron Health, Inc. The transaction, which is expected to close in the first half of 2018, is subject to customary closing conditions.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Flatiron Health, a privately held healthcare technology and services company, is a market leader in oncology-specific electronic health record (EHR) software, as well as the curation and development of real-world evidence for cancer research.
The Davis Polk corporate team includes partners Marc O. Williams and Brian Wolfe and associates Albert Zhu and Daisy Wu. Counsel David R. Bauer is providing intellectual property and technology advice. Partner Jean M. McLoughlin, counsel David Mollo-Christensen and associate Joshua S. Sills are providing executive compensation advice. Partner Michael Mollerus is providing tax advice. Counsel Michelle Ontiveros Gross is providing data privacy advice. Members of the Davis Polk team are based in the New York and Northern California offices.